Top Markets
#1 COTI COTI +40.13%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +32.72%
#3 Bitcoin Cash Bitcoin Cash +31.68%
#4 Fabric Protocol Fabric Protocol +31.09%
#5 GALA GALA +28.74%
#6 Tutorial Tutorial +27.35%
#7 Talus Network Talus Network +26.03%
#8 Magma Finance Magma Finance +24.61%
#9 Zora Zora +23.81%
#10 Arowana Arowana +22.89%
Coin of the day
COTI COTI
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Clasificación en acciones #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Precio por acción
$0.78611575
Capitalización bursátil
$60.45M
Cambio (1 día)
0.00%
Cambio (1 año)
-12.06%
País
NO
Comercio Lytix Biopharma AS (LYTIX)

Categoría

Healthcare
Ratio P/S de Lytix Biopharma AS (LYTIX)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Lytix Biopharma AS, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Lytix Biopharma AS desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH